Rodero-Romero, A.; Sainz de la Maza, S.; Fernández-Velasco, J.I.; Monreal, E.; Walo-Delgado, P.E.; Chico-GarcÃa, J.L.; Villarrubia, N.; RodrÃguez-Jorge, F.; RodrÃguez-Ramos, R.; Masjuan, J.;
et al. Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine. Vaccines 2023, 11, 1399.
https://doi.org/10.3390/vaccines11091399
AMA Style
Rodero-Romero A, Sainz de la Maza S, Fernández-Velasco JI, Monreal E, Walo-Delgado PE, Chico-GarcÃa JL, Villarrubia N, RodrÃguez-Jorge F, RodrÃguez-Ramos R, Masjuan J,
et al. Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine. Vaccines. 2023; 11(9):1399.
https://doi.org/10.3390/vaccines11091399
Chicago/Turabian Style
Rodero-Romero, Alexander, Susana Sainz de la Maza, José Ignacio Fernández-Velasco, Enric Monreal, Paulette Esperanza Walo-Delgado, Juan Luis Chico-GarcÃa, Noelia Villarrubia, Fernando RodrÃguez-Jorge, Rafael RodrÃguez-Ramos, Jaime Masjuan,
and et al. 2023. "Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine" Vaccines 11, no. 9: 1399.
https://doi.org/10.3390/vaccines11091399
APA Style
Rodero-Romero, A., Sainz de la Maza, S., Fernández-Velasco, J. I., Monreal, E., Walo-Delgado, P. E., Chico-GarcÃa, J. L., Villarrubia, N., RodrÃguez-Jorge, F., RodrÃguez-Ramos, R., Masjuan, J., Costa-Frossard, L., & Villar, L. M.
(2023). Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine. Vaccines, 11(9), 1399.
https://doi.org/10.3390/vaccines11091399